Functional assays revealed that knockdown of CPT1A significantly inhibited DLBCL cell proliferation and induced apoptosis.<h4>Conclusions</h4>Our study highlights fatty acid metabolism as a key prognostic indicator and immune regulator in DLBCL. This evidence concerns the gene CPT1A and diffuse large B-cell lymphoma.